Chapter 10 Viral infections of lower motor neurons

Handbook of Clinical Neurology

Volumn 82, Issue , 2007, Pages 179-206

  Solomon, Tom ^a   Ooi, Mong How ^a,b   Mallewa, Macpherson ^a,c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^c ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649373936     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)80013-3     Document Type: Article

References (245)

1. Agrawal A.G., and Petersen L.R. Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 188 (2003) 1-4
2. Akaike T., Weihe E., Schaefer M., Fu Z.F., Zheng Y.M., Vogel W., Schmidt H., Koprowski H., and Dietzschold B. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J Neurovirol 1 (1995) 118-125
3. Anonymous. Progress toward global eradication of poliomyelitis, 2002. MMWR Morb Mortal Wkly Rep 52 (2003) 366-369
4. Arras C., Fescharek R., and Gregersen J.P. Do specific hyperimmunoglobulins aggravate clinical course of tick-borne encephalitis?. Lancet 347 (1996) 1331
5. Baker A.B., Matzke H.A., and Brown J.R. Poliomyelitis III. Bulbar poliomyelitis; a study of medullary function. Archives of Neurology 1 (1950) 257-281
6. Barrett A.D. Current status of flavivirus vaccines. Ann N Y Acad Sci 951 (2001) 262-271
7. Belov G.A., Romanova L.I., Tolskaya E.A., Kolesnikova M.S., Lazebnik Y.A., and Agol V.I. The major apoptotic pathway activated and suppressed by poliovirus. J Virol 77 (2003) 45-56
8. Bennet N.M. Murray Valley encephalitis, 1974. Clinical features. Med J Aust 2 (1976) 446-454
9. Bista M.B., Banerjee M.K., Shin S.H., Tandan J.B., Kim M.H., Sohn Y.M., Ohrr H.C., Tang J.L., and Halstead S.B. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358 (2001) 791-795
10. Blomberg J., Lycke E., Ahlfors K., Johnsson T., Wolontis S., and von Zeipel G. New enterovirus type associated with epidemic of aseptic meningitis and/or hand, foot and mouth disease. Lancet 2 (1974) 112
11. Blondel B., Colbere-Garapin F., Couderc T., Wirotius A., and Guivel-Benhassine F. Poliovirus, pathogenesis of poliomyelitis, and apoptosis. Curr Top Microbiol Immunol 289 (2005) 25-56
12. Bodian D. Histopathological basis of the clinical findings in poliomyelitis. Am J Med 6 (1949) 563
13. Boos J., and Esiri M.M. Viral encephalitis in humans (2003), ASM Press, Washington, DC
14. Bosanko C.M., Gilroy J., Wang A.M., Sanders W., Dulai M., Wilson J., and Blum K. West Nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol 60 (2003) 1448-1452
15. Breinl A. Clinical pathological and experimental observations on the 'mysterious disease', a clinically aberrant form of poliomyelitis. Med J Aust 1 (1918) 209-229
16. Brinker K.R., and Monath T.P. The acute disease. In: Monath T.P. (Ed). St Louis Encephalitis (1980), American Public Health Associates, Washington, DC 503-534
17. Brown B.A., Oberste M.S., Alexander Jr. J.P., Kennett M.L., and Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 73 (1999) 9969-9975
18. Burke D.S., and Morill J.C. Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis. J Infect Dis 155 (1987) 797-799
19. Burke D.S., Lorsomrudee W., Leake C.J., Hoke C.H., Nisalak A., Chongswasdi V., and Laorakpongse T. Fatal outcome in Japanese encephalitis. Am J Trop Med Hyg 34 (1985) 1203-1210
20. Burke D.S., Nisalak A., Ussery M.A., Laorakpongse T., and Chantavibul S. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 151 (1985) 1093-1099
21. Burrow J.N., Whelan P.I., Kilburn C.J., Fisher D.A., Currie B.J., and Smith D.W. Australian encephalitis in the Northern Territory: clinical and epidemiological features, 1987-1996. Aust N Z J Med 28 (1998) 590-596
22. Cardosa M.J., Krishnan S., Tio P.H., Perera D., and Wong S.C. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet 354 (1999) 987-991
23. Cardosa M.J., Perera D., Brown B.A., Cheon D., Chan H.M., Chan K.P., Cho H., and McMinn P. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 9 (2003) 461-468
24. Catteau A., Courageot M.P., Despres P.,. Flaviviruses and apoptosis regulation. Prog Mol Subcell Biol 36 (2004) 118-171
25. Centers for Disease Control. Human rabies - California, Georgia, Minnesota, New York, and Wisconsin, 2000. MMWR Morb Mortal Wkly Rep 49 (2000) 1111-1115
26. Cerna F., Mehrad B., Luby J.P., Burns D., and Fleckenstein J.L. St. Louis encephalitis and the substantia nigra: MR imaging evaluation. AJNR Am J Neuroradiol 20 (1999) 1281-1283
27. Chambers T.J., and Diamond M.S. Pathogenesis of fla-vivirus encephalitis. Adv Virus Res 60 (2003) 273-342
28. Chambers T.J., Hahn C.S., Galler R., and Rice C.M. Flavivirus genome organisation, expression and replication. Ann Rev Microbiol 44 (1990) 649-688
29. Chan K.P., Goh K.T., Chong C.Y., Teo E.S., Lau G., and Ling A.E. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 9 (2003) 78-85
30. Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., Jegathesan M., and Anderson L.J. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 31 (2000) 678-683
31. Chang L.Y., Lin T.Y., Hsu K.H., Huang Y.C., Lin K.L., Hsueh C., Shih S.R., Ning H.C., Hwang M.S., Wang H.S., and Lee C.Y. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354 (1999) 1682-1686
32. Chang L.Y., Hsia S.H., Wu C.T., Huang Y.C., Lin K.L., Fang T.Y., and Lin T.Y. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J 23 (2004) 327-332
33. Chang L.Y., Tsao K.C., Hsia S.H., Shih S.R., Huang C.G., Chan W.K., Hsu K.H., Fang T.Y., Huang Y.C., and Lin T.Y. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. Jama 291 (2004) 222-227
34. Chaturvedi U.C., Mathur A., Chandra A., Das S.K., Tandon H.O., and Singh U.K. Transplacental infection with Japanese encephalitis virus. J Infect Dis 141 (1980) 712-715
35. Chen C.Y., Chang Y.C., Huang C.C., Lui C.C., Lee K.W., and Huang S.C. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am J Neuroradiol 22 (2001) 200-205
36. Chen W.R., Tesh R.B., and Rico-Hesse R. Genetic variation of Japanese encephalitis virus in nature. J Gen Virol 71 (1990) 2915-2922
37. Chen W.R., Rico-Hesse R., and Tesh R.B. A new genotype of Japanese virus from Indonesia. Am J Trop Med Hygiene 47 (1992) 61-69
38. Chen Y., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., and Marks R.M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulphate. Nature Med 3 (1997) 866-871
39. Chiba N., Osada M., Komoro K., Mizutani T., Kariwa H., and Takashima I. Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization. Vaccine 17 (1999) 1532-1539
40. Chopra J.S., Banerjee A.K., Murthy J.M., and Pal S.R. Paralytic rabies: a clinico-pathological study. Brain 103 (1980) 789-802
41. Chu J.J., and Ng M.L. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. J Biol Chem 279 (2004) 54533-54541
42. da Silva E.E., Winkler M.T., and Pallansch M.A. Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis 2 (1996) 231-233
43. Dalakas M., and Illa I. Post-polio syndrome: concepts in clinical diagnosis, pathogenesis, and etiology. Adv Neurol 56 (1991) 495-511
44. Dalakas M.C., Sever J.L., Madden D.L., Papadopoulos N.M., Shekarchi I.C., Albrecht P., and Krezlewicz A. Late postpoliomyelitis muscular atrophy: clinical, virologic, and immunologic studies. Rev Infect Dis 6 Suppl 2 (1984) S562-S567
45. Dalldorf G., and Sickles G.M. An unidentified, filterable agent isolated from the feces of children with paralysis. Science 108 (1948) 61-62
46. Davies N.W.S., Brown L.J., Gonde J., Irish D., Robinson R.O., Swan A.V., Banatvala J., Howard R.S., Sharief M.K., and Muir P. Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. J Neurol Neurosurg Psychiatry 76 (2005) 82-87
47. Available online at. Department of Health. Rabies - Draft Updated Chapter 27 of Immunisation against infectious disease 1996 - 'The Green Book'. Accessed 15 August 2005. (2004), Department of Health. http://www.dh.gov.uk/assetRoot/04/11/09/70/04110970.pdf
48. Desai A., Shankar S.K., Ravi V., Chandramuki A., and Gourie-Devi M. Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol (Berl) 89 (1995) 368-373
49. Despres P., Frenkiel M.P., Ceccaldi P.E., Duarte Dos Santos C., and Deubel V. Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J Virol 72 (1998) 823-829
50. Dolin R. Enterovirus 71 - emerging infections and emerging questions. N Engl J Med 341 (1999) 984-985
51. Dropulic B., and Masters C.L. Entry of neurotropic arboviruses into the central nervous system: an in vitro study using mouse brain endothelium. J Infect Dis 161 (1990) 685-691
52. Dutta J.K., Dutta T.K., and Das A.K. Human rabies: modes of transmission. J Assoc Physicians India 40 (1992) 322-324
53. Enders J.R., Weller T.H., and Robbins F.C. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109 (1949) 85-87
54. Evans D.M., Dunn G., Minor P.D., Schild G.C., Cann A.J., Stanway G., Almond J.W., Currey K., and Maizel Jr. J.V. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314 (1985) 548-550
55. (Suppl). Fooks A.R., Johnson N., Brookes S.M., Parsons G., and McElhinney L.M. Risk factors associated with travel to rabies endemic countries. J Appl Microbiol 94 (2003) 31S-36S
56. Fooks A.R., McElhinney L.M., Pounder D.J., Finnegan C.J., Mansfield K., Johnson N., Brookes S.M., Parsons G., White K., McIntyre P.G., and Nathwani D. Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis. J Med Virol 71 (2003) 281-289
57. French E.L. Murray Valley encephalitis: isolation and characterisation of the aetiological agent. Med J Aust 1 (1952) 100-103
58. Fu Z.F., and Jackson A.C. Neuronal dysfunction and death in rabies virus infection. J Neurovirol 11 (2005) 101-106
59. Gadoth N., Weitzman S., and Lehmann E.E. Acute anterior myelitis complicating West Nile fever. Arch Neurol 36 (1979) 172-173
60. George A., Prasad S.R., Rao J.A., Yergolkar P.N., and Setty C.V. Isolation of Japanese encephalitis and West Nile viruses from fatal cases of encephalitis in Kolar district of Karnataka. Ind J Med Res 86 (1987) 131-134
61. Glass W.G., Lim J.K., Cholera R., Pletnev A.G., Gao J.L., and Murphy P.M. Chemokine receptor CCR5 promotes leuko-cyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202 (2005) 1087-1098
62. Greenberg M., Abramson H., Cooper H.M., and Solomon H.E. The relationship between recent injections and paralytic poliomyelitis in children. Am J Public Health 42 (1952) 142
63. Gritsun T.S., Frolova T.V., Zhankov A.I., Armesto M., Turner S.L., Frolova M.P., Pogodina V.V., Lashkevich V.A., and Gould E.A. Characterization of a Siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J Virol 77 (2003) 25-36
64. Gromeier M., Mueller S., Solecki D., Bossert B., Bernhardt G., and Wimmer E. Determinants of poliovirus neurovirulence. J Neurovirol 3 Suppl 1 (1997) S35-S38
65. Gromeier M., and Wimmer E. Mechanism of injury-provoked poliomyelitis. J Virol 72 (1998) 5056-5060
66. Guarner J., Shieh W.J., Hunter S., Paddock C.D., Morken T., Campbell G.L., Marfin A.A., and Zaki S.R. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 35 (2004) 983-990
67. Haglund M., and Gunther G. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine 21 Suppl 1 (2003) S11-S18
68. Haley M., Retter A.S., Fowler D., Gea-Banacloche J., and O'Grady N.P. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin Infect Dis 37 (2003) e88-e90
69. Halstead S.B. The pathogenesis of dengue; molecular epidemiology in infectious disease. Am J Epidemiol 114 (1981) 632-648
70. Halstead S.B., and O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265 (1977) 739-741
71. Harinasuta C., Nimmanitya S., and Titsyakorn U. The effect of interferon alpha on two cases of Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health 16 (1985) 332-336
72. Hasegawa H., Satake Y., and Kobayashi Y. Effect of cytokines on Japanese encephalitis virus production by human monocytes. Microbiol Immunol 34 (1990) 459-466
73. Haymaker W., and Sabin A.B. Topographic distribution of lesions in central nervous system in Japanese B encephalitis. Nature of the lesions with report of a case on Okinawa. Arch Neurol Psychiatry 57 (1947) 673-692
74. Hemachudha T., Phanthumchinda K., Phanuphak P., and Manutsathit S. Myoedema as a clinical sign in paralytic rabies. Lancet 1 (1987) 1210
75. Hemachudha T., Laothamatas J., and Rupprecht C.E. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 1 (2002) 101-109
76. Hemachudha T., Wacharapluesadee S., Lumlertdaecha B., Orciari L.A., Rupprecht C.E., La-Ongpant M., Juntrakul S., and Denduangboripant J. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies. J Infect Dis 188 (2003) 960-966
77. Hinman A.R., Foege W.H., De Quadros C.A., Patharca P.A., Orenstein W.A., and Brink E.W. The case for global eradication of poliomyelitis. Bull WHO 65 (1987) 835-840
78. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., and Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341 (1999) 929-935
79. Hogle J.M., Chow M., and Filman D.J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229 (1985) 1358-1365
80. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., Kotchasenee S., Gingrich J.B., Latendresse J., Fukai K., et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319 (1988) 608-614
81. Horstmann D.M. Acute poliomyelitis relation of physical activity at the time of onset to the course of the disease. J Am Med Assoc 142 (1950) 236-241
82. Horstmann D.W. Clinical aspects of acute poliomyelitis. Am J Med 6 (1949) 592
83. Hsueh C., Jung S.-M., Shih S.-R., Kuo T.-T., Shieh W.-J., Zaki S., Lin T.-Y., Chang L.-Y., Ning H.-C.S.M., and Yen D.-C. Acute encephalomyelitis during an Outbreak of Enterovirus Type 71 Infection in Taiwan: Report of an autopsy case with pathologic, immunofluorescence, and mole. Mod Pathol 13 (2000) 1200-1205
84. Huang C., Slater B., Rudd R., Parchuri N., Hull R., Dupuis M., and Hindenburg A. First Isolation of West Nile virus from a patient with encephalitis in the United States. Emerg Infect Dis 8 (2002) 1367-1371
85. Huang C.C., Liu C.C., Chang Y.C., Chen C.Y., Wang S.T., and Yeh T.F. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341 (1999) 936-942
86. Huang C.H. Studies of Japanese encephalitis in China. Adv Virus Res 27 (1982) 71-101
87. Huang C.H., and Wong C. Relation of the peripheral multiplication of Japanese B encephalitis virus to the pathogenesis of the infection in mice. Acta Virological 7 (1963) 322-330
88. Huang F.L., Jan S.L., Chen P.Y., Chi C.S., Wang T.M., Fu Y.C., Tsai C.R., and Chang Y. Left ventricular dysfunction in children with fulminant enterovirus 71 infection: an evaluation of the clinical course. Clin Infect Dis 34 (2002) 1020-1024
89. Igarashi A., Tanaka M., Morita K., Morita K., Takasu T., Ahmed A., Ahmed A., Akram D.S., and Waqar M.A. Detection of West Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol 38 (1994) 827-830
90. Innis B.L., Nisalak A., Nimmannitya S., Kusalerdchariya S., Chongswasdi V., Suntayakorn S., Puttisri P., and Hoke C.H. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hygiene 40 (1989) 418-427
91. Iwamoto M., Jernigan D.B., Guasch A., Trepka M.J., Blackmore C.G., Hellinger W.C., Pham S.M., Zaki S., Lanciotti R.S., Lance-Parker S.E., DiazGranados C.A., Winquist A.G., Perlino C.A., Wiersma S., Hillyer K.L., Goodman J.L., Marfin A.A., Chamberland M.E., and Petersen L.R. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 348 (2003) 2196-2203
92. Iwasaki Y., and Tobita M. Pathology. In: Jackson A.C., and Wunner W.H. (Eds). Rabies (2002), Academic Press, San Diego 283-306
93. Jackson A.C. Rabies. Can J Neurol Sci 27 (2000) 278-282
94. Jackson A.C. Rabies virus infection: an update. J Neurovirol 9 (2003) 253-258
95. Jackson A.C., and Rossiter J.P. Apoptosis plays an important role in experimental rabies virus infection. J Virol 71 (1997) 5603-5607
96. Jackson A.C., and Fenton M.B. Human rabies and bat bites. Lancet 357 (2001) 1714
97. Jackson A.C., Warrell M.J., Rupprecht C.E., Ertl H.C., Dietzschold B., O'Reilly M., Leach R.P., Fu Z.F., Wunner W.H., Bleck T.P., and Wilde H. Management of rabies in humans. Clin Infect Dis 36 (2003) 60-63
98. Javadi M.A., Fayaz A., Mirdehghan S.A., and Ainollahi B. Transmission of rabies by corneal graft. Cornea 15 (1996) 431-433
99. Jeha L.E., Sila C.A., Lederman R.J., Prayson R.A., Isada C.M., and Gordon S.M. West Nile virus infection: a new acute paralytic illness. Neurology 61 (2003) 55-59
100. Jia L.L., Zheng A., and Yu Y.X. Study on the immune mechanism of JE attenuated live vaccine (SA14 -14-2 strain) in immune inhibited mice. Chin J Immunol Microbiol 12 (1992) 364
101. John T.J. Spinal cord disease in West Nile virus infection. N Engl J Med 348 (2003) 564-566
102. Johnson N., Brookes S.M., Fooks A.R., and Ross R.S. Review of human rabies cases in the UK and in Germany. Vet Rec 157 (2005) 715
103. Johnson R.T., Burke D.S., Elwell M., Leake C.J., Nisalak A., Hoke C.H., and Lorsomrudee W. Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18 (1985) 567-573
104. Johnson R.T., and Cornblath D.R. Poliomyelitis and flaviviruses. Ann Neurol 53 (2003) 691-692
105. Johnston L.J., Halliday G.M., and King N.J. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J Invest Dermatol 114 (2000) 560-568
106. Julian K.G., Eidson M., Kipp A.M., Weiss E., Petersen L.R., Miller J.R., Hinten S.R., and Marfin A.A. Early season crow mortality as a sentinel for West Nile virus disease in humans, northeastern United States. Vector Borne Zoonotic Dis 2 (2002) 145-155
107. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain 122 (1999) 2067-2078
108. Kelley T.W., Prayson R.A., and Isada C.M. Spinal cord disease in West Nile virus infection. N Engl J Med 348 (2003) 564-566
109. Kennett M.L., Birch C.J., Lewis F.A., Yung A.P., and Locarnini S.A. Enterovirus type 71 infections in Melbourne. Bull WHO 51 (1974) 609-615
110. ienzle N., and Boyes L. Murray Valley encephalitis: case report and review of neuroradiological features. Aust Radiol 47 (2003) 61-63
111. Komar N., Langevin S., Hinten S., Nemeth N., Edwards E., Hettler D., Davis B., Bowen R., and Bunning M. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 9 (2003) 311-322
112. Kumar R., Mathur A., Kumar A., Sharma S., Chakraborty S., and Chaturvedi U.C. Clinical features and prognostic indicators of Japanese encephalitis in children in Lucknow (India). Ind J Med Res 91 (1990) 321-327
113. Kunz C. Vaccination against TBE in Austria: the success story continues. Int J Med Microbiol 291 Suppl 33 (2002) 56-57
114. (Pt 3). Ladogana A., Bouzamondo E., Pocchiari M., and Tsiang H. Modification of tritiated gamma-amino-n-butyric acid transport in rabies virus-infected primary cortical cultures. J Gen Virol 75 (1994) 623-627
115. Lanciotti R.S., Kerst A.J., Nasci R.S., Godsey M.S., Mitchell C.J., Savage H.M., Komar N., Panella N.A., Allen B.C., Volpe K.E., Davis B.S., and Roehrig J.T. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 38 (2000) 4066-4071
116. Landsteiner K., and Popper E. Ubertragung der Poliomyelitis acuta auf Affen. Z Immun Forsch 2 (1909) 377-390
117. Laothamatas J., Hemachudha T., Mitrabhakdi E., Wannakrairot P., and Tulayadaechanont S. MR imaging in human rabies. AJNR Am J Neuroradiol 24 (2003) 1102-1109
118. Leis A.A., Stokic D.S., Polk J.L., Dostrow V., and Winkelmann M. A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med 347 (2002) 1279-1280
119. Leis A.A., Fratkin J., Stokic D.S., Harrington T., Webb R.M., and Slavinski S.A. West Nile poliomyelitis. Lancet Infect Dis 3 (2003) 9-10
120. Leon-Monzon M.E., and Dalakas M.C. Detection of poliovirus antibodies and poliovirus genome in patients with the post-polio syndrome. Ann NY Acad Sci 753 (1995) 208-218
121. Li J., Loeb J.A., Shy M.E., Shah A.K., Tselis A.C., Kupski W.J., and Lewis R.A. Asymmetric flaccid paralysis: A neuro-muscular presentation of West Nile virus infection. Ann Neurol 53 (2003) 703-710
122. Liao C.L., Lin Y.L., Wang J.J., Huang Y.L., Yeh C.T., Ma S.H., and Chen L.K. Effect of enforced expression of human bcl-2 on Japanese encephalitis virus induced apoptosis in cultured cells. J Virol 71 (1997) 5963-5971
123. Liao C.L., Lin Y.L., Shen S.C., Shen J.Y., Su H.L., Huang Y.L., Ma S.H., Sun Y.C., Chen K.P., and Chen L.K. Antiapoptotic but not antiviral function of human bcl-2 assists establishment of Japanese encephalitis virus persistence in cultured cells. J Virol 72 (1998) 9844-9854
124. Libraty D.H., Nisalak A., Endy T.P., Suntayakorn S., Vaughn D.W., and Innis B.L. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg 96 (2002) 173-178
125. Lin C.W., and Wu S.C. A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combiningsites. J Virol 77 (2003) 2600-2606
126. Lin T.Y., Chang L.Y., Hsia S.H., Huang Y.C., Chiu C.H., Hsueh C., Shih S.R., Liu C.C., and Wu M.H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 34 Suppl 2 (2002) S52-S57
127. Lin T.Y., Chang L.Y., Huang Y.C., Hsu K.H., Chiu C.H., and Yang K.D. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr 91 (2002) 632-635
128. Liou M.-L., and Hsu C.-Y. Japanese encephalitis virus is transported across the cerebral blood vessels by endocytosis in mouse brain. Cell Tissue Res 293 (1998) 389-394
129. Liu Y.F., Teng C.L., and Liu K. Cerebral cysticercosis as a factor aggravating Japanese B encephalitis. Chin Med J 75 (1957) 1010
130. Lum L.C., Wong K.T., Lam S.K., Chua K.B., Goh A.Y., Lim W.L., Ong B.B., Paul G., AbuBakar S., and Lambert M. Fatal enterovirus 71 encephalomyelitis. J Pediatr 133 (1998) 795-798
131. Martin D.A., Biggerstaff B.J., Allen B., Johnson A.J., Lanciotti R.S., and Roehrig J.T. Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 9 (2002) 544-549
132. Maschke M., Kastrup O., Forsting M., and Diener H.C. Update on neuroimaging in infectious central nervous system disease. Curr Opin Neurol 17 (2004) 475-480
133. Mathur A., Khamia N., and Chaturvedi U.C. Breakdown of blood-brain barrier by virus induced cytokine during Japanese encephalitis virus infection. Int J Exp Pathol 73 (1992) 603-611
134. McCordock J.A., Collier W., and Gray S.H. The pathological changes of the St Louis type of acute encephalitis. J Am Med Assoc 103 (1934) 822-825
135. McMinn P., Lindsay K., Perera D., Chan H.M., Chan K.P., and Cardosa M.J. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 75 (2001) 7732-7738
136. McMinn P., Stratov I., Nagarajan L., and Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 32 (2001) 236-242
137. McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26 (2002) 91-107
138. Melnick J.L., and Ledinko N. Social serology: antibody levels in a normal young population during an epidemic of poliomyelitis. Am J Hygiene 54 (1951) 354
139. Mendelsohn C.L., Wimmer E., and Racaniello V.R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56 (1989) 855-865
140. Meyer H.M., Johnson R.T., and Crawford I.P. Central nervous system syndromes of viral etiology. A study of 713 cases. Am J Med 29 (1960) 334
141. Misra U.K., and Kalita J. Anterior horn cells are also involved in Japanese encephalitis. Acta Neurolog Scand 96 (1997) 114-117
142. Misra U.K., and Kalita J. Movement disorders in Japanese encephalitis. J Neurol 244 (1997) 299-303
143. Mitrabhakdi E., Shuangshoti S., Wannakrairot P., Lewis R.A., Susuki K., Laothamatas J., and Hemachudha T. Difference in neuropathogenetic mechanisms in human furious and paralytic rabies. J Neurol Sci 238 (2005) 3-10
144. Miyake M. The pathology of Japanese encephalitis. Bull WHO 30 (1964) 153-160
145. Modlin J.F. Coxsackieviruses, echoviruses, and newer enteroviruses. In: Mandell G.L., Bennet J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases Vol. 2 (1995), Churchill Livingstone Inc, New York 1621-1636
146. Modlin J.F. Poliovirus. In: Mandell G.L., Bennet J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases Vol. 2 (1995), Churchill Livingstone Inc, New York 1613-1620
147. Monath T.P. Epidemiology. In: Monath T.P. (Ed). St Louis Encephalitis (1980), American Public Health Associates, Washington DC 239-312
148. Monath T.P. Japanese encephalitis vaccines: current vaccines and future prospects. Curr Top Microbiol Immunol 267 (2002) 105-138
149. Monath T.P., Cropp C.P., and Harrison A.K. Mode of entry of a neurotropic virus into the central nervous system. Reinvestigation of an old controversy. Lab Invest 48 (1983) 399-410
150. Mostashari F., Bunning M.L., Kitsutani P.T., Singer D.A., Nash D., Cooper M.J., Katz N., Liljebjelke K.A., Biggerstaff B.J., Fine A.D., Layton M.C., Mullin S.M., Johnson A.J., Martin D.A., Hayes E.B., and Campbell G.L. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepide-miological survey. Lancet 358 (2001) 261-264
151. Mueller S., Cao X., Welker R., and Wimmer E. Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis. J Biol Chem 277 (2002) 7897-7904
152. Mueller S., Wimmer E., and Cello J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res 111 (2005) 175-193
153. Myint K.S., Raengsakulrach B., Young G.D., Gettayacamin M., Ferguson L.M., Innis B.L., Hoke C.H.J., and Vaughn D.W. Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus. Am J Trop Med Hygiene 60 (1999) 338-342
154. Nash D., Mostashari F., Fine A., Miller J., O'Leary D., Murray K., Huang A., Rosenberg A., Greenberg A., Sherman M., Wong S., and Layton M. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344 (2001) 1807-1814
155. Nathanson N., and Bodian D. Experimental poliomyelitis following intramuscular virus injection. III. The effect of passive antibody on paralysis and viremia. Bull Johns Hopkins Hosp 111 (1962) 198-220
156. Nathanson N., and Martin J.R. The epidemiology of poliomyelitis: enigmas surrounding its appearance, periodicity and disappearance. Am J Epidemiol 110 (1979) 672-692
157. Newman W., and Southam C.M. Virus treatment in advanced cancer. A pathological study of fifty-seven cases. Cancer 7 (1954) 106-118
158. (Pt 7). Ni H., and Barrett A.D. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J Gen Virol 77 (1996) 1449-1455
159. Nir Y., Beemer A., and Goldwasser R.A. West Nile Virus infection in mice following exposure to a viral aerosol. Br J Exp Pathol 46 (1965) 443-449
160. Okhuysen P.C., Crane J.K., and Pappas J. St Louis encephalitis in patients with human immunodeficiency virus infection. Clin Infect Dis 17 (1993) 140-141
161. Park M., Hui J.S., and Bartt R.E. Acute anterior radiculitis associated with West Nile virus infection. J Neurol Neurosurg Psychiatry 74 (2003) 823-825
162. Parquet M.C., Kumatori A., Hasebe F., Morita K., and Igarashi A. West Nile virus-induced bax-dependent apoptosis. FEBS Lett 500 (2001) 17-24
163. Pepperell C., Rau N., Krajden S., Kern R., Humar A., Mederski B., Simor A., Low D.E., McGeer A., Mazzulli T., Burton J., Jaigobin C., Fearon M., Artsob H., Drebot M.A., Halliday W., and Brunton J. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 168 (2003) 1399-1405
164. Petersen L.R., and Marfin A.A. West Nile virus: a primer for the clinician. Ann Intern Med 137 (2002) 173-179
165. Petersen L.R., Roehrig J.T., and Hughes J.M. West Nile virus encephalitis. N Engl J Med 347 (2002) 1225-1226
166. Petersen L.R., Roehrig J.T., and Hughes J.M. West Nile virus encephalitis. N Engl J Med 347 (2002)
167. Rahal J.J., Anderson J., Rosenberg C., Reagan T., and Thompson L.L. Effect of interferon-alpha 2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis 190 (2004) 1084-1087
168. Ravi V., Parida S., Desai A., Chandramuki A., Gourie-Devi M., and Grau G.E. Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 51 (1997) 132-136
169. Ren R., and Racaniello V.R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis 166 (1992) 747-752
170. Rey F.A., Heinz F.X., Mandl C., Kunz C., and Harrison C. The envelope glycoprotein from tick-borne encephalitis virus at 2 resolution. Nature 375 (1995) 291-298
171. Reyes-Del Valle J., Chavez-Salinas S., Medina F., and Del Angel R.M. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 79 (2005) 4557-4567
172. Roehrig J.T., Hunt A.R., Johnson A.J., and Hawkes R.A. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology 171 (1989) 49-60
173. Roehrig J.T., Nash D., Maldin B., Labowitz A., Martin D.A., Lanciotti R.S., and Campbell G.L. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile Virus encephalitis cases. Emerg Infect Dis 9 (2003) 376-379
174. Rotbart H.A., and Webster A.D. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 32 (2001) 228-235
175. Russell W.R. Paralytic poliomyelitis: the early symptoms and the effect of physical activity on the course of the disease. Br Med J 1 (1949) 465
176. Sabin A.B. Paralytic poliomyelitis: Old dogmas and new perspectives. Rev Infect Dis 3 (1981) 543-564
177. Sampson B.A., Ambrosi C., Charlot A., Reiber K., Veress J.F., and Armbrustmacher V. The pathology of human West Nile Virus infection. Human Pathol 31 (2000) 527-531
178. Samuda G.M., Chang W.K., Yeung C.Y., and Tang P.S. Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J 6 (1987) 206-208
179. Samuel M.A., and Diamond M.S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79 (2005) 13350-13361
180. Sato T., Irie K., Ooshio T., Ikeda W., and Takai Y. Involvement of heterophilic trans-interaction of Necl-5/Tage4/PVR/CD155 with nectin-3 in formation of nectin- and cadherin-based adherens junctions. Genes Cells 9 (2004) 791-799
181. Schmidt N.J., Lennette E.H., and Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129 (1974) 304-309
182. Sejvar J.J., Haddad M.B., Tierney B.C., Campbell G.L., Marfin A.A., Van Gerpen J.A., Fleischauer A., Leis A.A., Stokic D.S., and Petersen L.R. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290 (2003) 511-515
183. Sejvar J.J., Leis A.A., Stokic D.S., Van Gerpen J.A., Marfin A.A., Webb R., Haddad M.B., Tierney B.C., Slavinski S.A., Polk J.L., Dostrow V., Winkelmann M., and Petersen L.R. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 9 (2003) 788-793
184. Sejvar J.J., Bode A.V., Marfin A.A., Campbell G.L., Ewing D., Mazowiecki M., Pavot P.V., Schmitt J., Pape J., Biggerstaff B.J., and Petersen L.R. West Nile virus-associated flaccid paralysis. Emerg Infect Dis 11 (2005) 1021-1027
185. Shah V.A., Chong C.Y., Chan K.P., Ng W., and Ling A.E. Clinical characteristics of an outbreak of hand, foot and mouth disease in Singapore. Ann Acad Med Singapore 32 (2003) 381-387
186. Shankar S.K., Rao T.V., Mruthyunjayana B.P., Gourie Devi M., and Deshpande D.H. Autopsy study of brains during an epidemic of Japanese encephalitis in Karnataka. Ind J Med Res 78 (1983) 431-441
187. Shen J., T-To S.S., Schrieber L., and King N.J. Early E-selectin, VCAM-1, ICAM-1, and late major histocom-patibility complex antigen induction on human endothelial cells by flavivirus andcomodulation of adhesion molecule expression by immune cytokines. J Virol 71 (1997) 9323-9332
188. Shen W.C., Chiu H.H., Chow K.C., and Tsai C.H. MR imaging findings of enteroviral encephaloymelitis: an outbreak in Taiwan. AJNR Am J Neuroradiol 20 (1999) 1889-1895
189. Shen W.C., Tsai C., Chiu H., and Chow K. MRI of Enterovirus 71 myelitis with monoplegia. Neuroradiology 42 (2000) 124-127
190. Shieh W.J., Guarner J., Layton M., Fine A., Miller J., Nash D., Campbell G., Roehrig J.T., Gubler D.J., and Zaki S.R. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis 6 (2000) 370-372
191. Shimizu H., Utama A., Onnimala N., Li C., Li-Bi Z., Yu-Jie M., Pongsuwanna Y., and Miyamura T. Molecular epidemi-ology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int 46 (2004) 231-235
192. Shimoni Z., Niven M.J., Pitlick S., and Bulvik S. Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 7 (2001) 759
193. Shindarov L.M., Chumakov M.P., Voroshilova M.K., Bojinov S., Vasilenko S.M., Iordanov I., Kirov I.D., Kamenov E., Leshchinskaya E.V., Mitov G., Robinson I., Sivchev S., and Staikov S. Epidemiological, clinical, and patho-morphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hygiene Epidemiol Microbiol Immunol 23 (1979) 284-295
194. Shrestha B., and Diamond M.S. Role of CD8 T cells in control of West Nile virus infection. J Virol 78 (2004) 8312-8321
195. Siger L., Bowen R.A., Karaca K., Murray M.J., Gordy P.W., Loosmore S.M., Audonnet J.C., Nordgren R.M., and Minke J.M. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nilevirus-infected mosqui-toes in horses. Am J Vet Res 65 (2004) 1459-1462
196. Sipahioglu U., and Alpaut S. Transplacental rabies in humans. Mikrobiyol Bul 19 (1985) 95-99
197. Smith J., McElhinney L., Parsons G., Brink N., Doherty T., Agranoff D., Miranda M.E., and Fooks A.R. Case report: rapid ante-mortem diagnosis of a human case of rabies imported into the UK from the Philippines. J Med Virol 69 (2003) 150-155
198. Smorodintsev A.A. Tick-borne spring-summer encephalitis. Prog Med Virol 1 (1958) 210-248
199. Solomon T. Current concepts - Flavivirus encephalitis. N Engl J Med 351 (2004) 370-378
200. in press. Solomon T., and Barrett A.D. Dengue. In: Nath A., and Berger J. (Eds). Neurovirology (2003), Marcel Decker, New York
201. Solomon T., and Vaughn D.W. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. In: Mackenzie J.S., Barrett A.D., and Deubel V. (Eds). Current Topics in Microbiology and Immunology: Japanese Encephalitis and West Nile Virus Infections Vol. 267 (2002), Springer-Verlag, Berlin 171-194
202. Solomon T., and Ravi V. Acute flaccid paralysis caused by West Nile virus. Lancet Infect Dis 3 (2003) 189
203. Solomon T., and Willison H. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis 16 (2003) 375-381
204. Solomon T., Kneen R., Dung N.M., Khanh V.C., Thuy T.T.N., Ha D.Q., Day N.P.J., Nisalak A., Vaughn D.W., and White N.J. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 351 (1998) 1094-1097
205. Solomon T., Thao L.T.T., Dung N.M., Kneen R., Hung N.T., Nisalak A., Vaughn D.W., Farrar J., Hien T.T., White N.J., and Cardosa M.J. Rapid diagnosis of Japanese encephalitis by using an IgM dot enzyme immunoassay. J Clin Microbiol 36 (1998) 2030-2034
206. Solomon T., Dung N.M., Kneen R., Gainsborough M., Vaughn D.W., and Khanh V.T. Japanese encephalitis. J Neurol Neurosurg Psychiatry 68 (2000) 405-415
207. Solomon T., Dung N.M., Kneen R., Thao L.T., Gainsborough M., Nisalak A., Day N.P., Kirkham F.J., Vaughn D.W., Smith S., and White N.J. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain 125 (2002) 1084-1093
208. Solomon T., Dung N.M., Wills B., Kneen R., Gainsborough M., Diet T.V., Thuy T.T.N., Loan H.T., Khanh V.C., Vaughn D.W., White N.J., and Farrar J.J. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 361 (2003) 821-826
209. Solomon T., Fisher A.F., Beasley D.W., Mandava P., Granwehr B.P., Langsjoen H., Travassos Da Rosa A.P., Barrett A.D., and Tesh R.B. Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clin Infect Dis 36 (2003) E140-E145
210. Solomon T., Ni H., Beasley D.W., Ekkelenkamp M., Cardosa M.J., and Barrett A.D. Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia. J Virol 77 (2003) 3091-3098
211. Solomon T., Ooi M.H., Beasley D.W., and Mallewa M. West Nile encephalitis. BMJ 326 (2003) 865-869
212. Solomon T., Marston D., Mallewa M., Felton T., Shaw S., McElhinney L.M., Das K., Mansfield K., Wainwright J., Kwong G.N., and Fooks A.R. Paralytic rabies after a two week holiday in India. BMJ 331 (2005) 501-503
213. Srinivasan A., Burton E.C., Kuehnert M.J., Rupprecht C., Sutker W.L., Ksiazek T.G., Paddock C.D., Guarner J., Shieh W.J., Goldsmith C., Hanlon C.A., Zoretic J., Fischbach B., Niezgoda M., El-Feky W.H., Orciari L., Sanchez E.Q., Likos A., Klintmalm G.B., Cardo D., LeDuc J., Chamberland M.E., Jernigan D.B., and Zaki S.R. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 352 (2005) 1103-1111
214. Starlin R., Reed N., Leeman B., Black J., Trulock E., and Mundy L.M. Acute flaccid paralysis syndrome associated with echovirus 19, managed with pleconaril and intravenous immunoglobulin. Clin Infect Dis 33 (2001) 730-732
215. Strady A., Lang J., Lienard M., Blondeau C., Jaussaud R., and Plotkin S.A. Antibody persistence following preex-posure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 177 (1998) 1290-1295
216. Su C.M., Liao C.L., Lee Y.L., and Lin Y.L. Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286 (2001) 206-215
217. Sutter R.W., Patriarca P.A., Suleiman A.J.M., Brogan S., Malankar P.G., Cochi S.L., Al-Ghassani A.A., and el-Bualy M.S. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitism during a largeoutbreak in Oman. J Infect Dis 165 (1992) 444-449
218. Tsao K.C., Chan E.C., Chang L.Y., Chang P.Y., Huang C.G., Chen Y.P., Chang S.C., Lin T.Y., Sun C.F., and Shih S.R. Responses of IgM for enterovirus 71 infection. J Med Virol 68 (2002) 574-580
219. Waldvogel K., Bossart W., Huisman T., Boltshauser E., and Nadal D. Severe tick-borne encephalitis following passive immunization. Eur J Pediatr 155 (1996) 775-779
220. Wang J.R., Tuan Y.C., Tsai H.P., Yan J.J., Liu C.C., and Su I.J. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 40 (2002) 10-15
221. Wang S.M., Liu C.C., Tseng H.W., Wang J.R., Huang C.C., Chen Y.J., Yang Y.J., Lin S.J., and Yeh T.F. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29 (1999) 184-190
222. Wang S.M., Lei H.Y., Huang K.J., Wu J.M., Wang J.R., Yu C.K., Su I.J., and Liu C.C. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients withpulmonary edema. J Infect Dis 188 (2003) 564-570
223. Warrell D.A., and Warrell M.J. Human rabies and its preven-tion: an overview. Rev Infect Dis 10 Suppl 4 (1988) S726-S731
224. Warrell M.J. Rabies. In: Cook G., and Zumlar A. (Eds). Manson's Tropical Diseases (2003), Saunders, London 807-821
225. Warrell M.J., and Warrell D.A. Rabies and other lyssavirus diseases. Lancet 363 (2004) 959-969
226. Wasay M., Diaz-Arrastia R., Suss R.A., Kojan S., Haq A., Burns D., and Van Ness P. St Louis encephalitis: a review of 11 cases in a 1995 Dallas, Tex, epidemic. Arch Neurol 57 (2000) 114-118
227. Webster A.D. Pleconaril - an advance in the treatment of enteroviral infection in immuno-compromised patients. J Clin Virol 32 (2005) 1-6
228. Weinstein L., Shelokov A., and Seltser R. A comparison of the clinical features of poliomyelitis in adults and children. N Engl J Med 246 (1952) 296
229. Weiss D., Carr D., Kellachan J., Tan C., Phillips M., Bresnitz E., and Layton M. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 7 (2001) 654-658
230. Willoughby Jr. R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., and Rupprecht C.E. Survival after treatment of rabies with induc-ion of coma. N Engl J Med 352 (2005) 2508-2514
231. Winkler W.G., Fashinell T.R., Leffingwell L., Howard P., and Conomy P. Airborne rabies transmission in a laboratory worker. Jama 226 (1973) 1219-1221
232. Winter P.M., Dung N.M., Loan H.T., Kneen R., Wills B., Thule T., House D., White N.J., Farrar J.J., Hart C.A., and Solomon T. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis 190 (2004) 1618-1626
233. Wittesj B., Eitrem R., Niklasson B., Vene S., and Mangiafico J.A. Japanese encephalitis after a 10-day holiday in Bali. Lancet 345 (1995) 856
234. World Health Assembly. Global eradication of poliomyelitis by the year 2000 (1988), World Health Organization, Geneva
235. World Health Organization. Acute onset flaccid paralysis (1993), WHO, Geneva
236. World Health Organization. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies (2005), World Health Organization, Geneva
237. Wu J.M., Wang J.N., Tsai Y.C., Liu C.C., Huang C.C., Chen Y.J., and Yeh T.F. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics 109 (2002) e26
238. Wu S.J., Grouard-Vogel G., Sun W., Mascola J.R., Brachtel E., Putvatana R., Louder M.K., Filgueira L., Marovich M.A., Wong H.K., Blauvelt A., Murphy G.S., Robb M.L., Innes B.L., Birx D.L., Hayes C.G., and Frankel S.S. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6 (2000) 816-820
239. Wyatt H.V. Provocation of poliomyelitis by multiple injections. Trans R Soc Trop Med Hygiene 79 (1985) 355-358
240. Yan J.J., Wang J.R., Liu C.C., Yang H.B., and Su I.J. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminantencephalitis. J Clin Virol 17 (2000) 13-22
241. Yang J.S., Ramanathan M.P., Muthumani K., Choo A.Y., Jin S.H., Yu Q.C., Hwang D.S., Choo D.K., Lee M.D., Dang K., Tang W., Kim J.J., and Weiner D.B. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerg Infect Dis 8 (2002) 1379-1384
242. Yang K.D., Yang M.Y., Li C.C., Lin S.F., Chong M.C., Wang C.L., Chen R.F., and Lin T.Y. Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J Infect Dis 183 (2001) 850-856
243. Yang W.X., Terasaki T., Shiroki K., Ohka S., Aoki J., Tanabe S., Nomura T., Terada E., Sugiyama Y., and Nomoto A. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229 (1997) 421-428
244. Yu W.X., Wang J.F., Zheng G.M., and Li H.M. Response of normal and athymic mice to infection by virulent and attenuated Japanese encephalitis virus. Clin J Virol 1 (1985) 203-209
245. Zimmerman H.M. The pathology of Japanese B encephalitis. Am J Pathol 22 (1946) 965-991